HPRA Drug Safety Newsletter Issue 122 08 April 2026
08/04/2026
Medicines for human use
Safety update
The latest edition of the HPRA newsletter includes important updates to support the safe and appropriate use of the following medicines:
- Hydroxycarbamide-containing medicinal products: Potential interference with continuous glucose monitoring systems
- Miconazole: Drug-drug interaction between miconazole topical formulations and warfarin
- Reporting suspected adverse reactions: The importance of reports of suspected adverse reactions to pharmacovigilance
- Product information updates recommended by the EMA’s Pharmacovigilance Risk Assessment Committee (PRAC)
- Direct Healthcare Professional Communications published on the HPRA website since the last Drug Safety Newsletter